BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Sanofi at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Sanofi takes part in 3 sessions at BIO-Europe 2026 in Cologne. Its role spans opening the regulatory strategy track, a panel on regulatory incentives and market exclusivity, and an introduction to Sanofi for dealmakers. Sanofi, which develops medicines and vaccines in immunology, rare diseases and neurology, also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
Sanofi
Paris, France
◆Gold Sponsor
Large pharmaGold sponsor
Pharmaceutical company developing medicines and vaccines in immunology, rare diseases, neurology and other areas.
Panel
Tue Nov 10
09:00–09:45
Accelerating Innovation and Market Exclusivity Through Regulatory Incentives
How updated EU drug laws and the Biotech Act change how long new medicines are shielded from competing copies, compared with rules elsewhere.
with European Commission, Swedish Medical Products Agency, Novartis
Chair
Tue Nov 10
08:55–09:00
Chair’s Welcome
Regulatory Strategy
Talk
Tue Nov 10
09:45–10:00
Pharma Presentation: Sanofi
How Sanofi uses its knowledge of the immune system, and AI, to invent medicines and vaccines.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Sanofi

Tell us what you sell and we’ll find the people at Sanofi most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction